医
China Med Service
Best doctors, yours
Breaking down language, channel and process barriers in cross-border care — making the best doctors your personal doctors.
300 Grade-A partner hospitals · 3,000+ leading experts · one-stop service across all specialties
Progressive systemic scleroderma (M34.000) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Dermatopolymyositis with lung involvement () is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Dermatopolymyositis (M33.900) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Polymyositis with pulmonary interstitial fibrosis () is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being c
Progressive polymyositis; glucocorticoids + methotrexate/azathioprine/IVIG; monitor ILD; follow-up rheumatology.
风湿免疫科Polymyositis is idiopathic inflammatory myopathy; glucocorticoids + methotrexate/azathioprine/IVIG; screen for malignancy; PT; follow-up rheumatology.
风湿免疫科Poikiloderma-associated dermatomyositis (M33.105) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being comp
Amyopathic dermatomyositis (skin-only DM); topical/systemic hydroxychloroquine; sun protection; monitor for conversion to classic DM/malignancy; follow-up dermatology/rheumatology.
风湿免疫科Dermatomyositis-associated pulmonary interstitial fibrosis () is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction i
Dermatomyositis-associated peripheral neuropathy () is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being co
Dermatomyositis is idiopathic inflammatory myopathy with rash; glucocorticoids + methotrexate/azathioprine/IVIG; screen for malignancy; sun protection; follow-up rheumatology/dermatology.
风湿免疫科Amyopathic dermatomyositis (M33.100x005) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Adult dermatomyositis (M33.100x004) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Childhood dermatomyositis (M33.100x001) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Other dermatomyositis (M33.100) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Juvenile dermatomyositis with lung involvement () is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being comp
Occult systemic lupus erythematosus (M32.901) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled
SLE is autoimmune multisystem disease; hydroxychloroquine base; glucocorticoids + immunosuppressants by organ involvement; avoid UV; follow-up rheumatology.
风湿免疫科Other forms of SLE (M32.800) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Lupus serositis () is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
|
